Q. When diagnosing depression in a client, how concerned should I be about identifying specific depression subtypes? Do specific subtypes suggest different treatment modalities? A. For years now, clinicians have attempted to categorize depressions into “subtypes.” A few examples are: typical vs. atypical, reactive vs. biological and psychotic vs. non-psychotic. There are as many as [...]
“Fat” is a bad word in our society, but omega-3 fatty acids are one of the superstars when it comes to improving nerve conduction. High levels of omega-3 fatty acids in the brain also reduce neuroinflammation, a factor commonly seen in people with depression. Cell membranes consist partly of omega-3s, which make it easier for [...]
On December 4, 2009, the FDA approved the use of two more antipsychotic medications — Zyprexa and Seroquel — for treating schizophrenia and bipolar disorder in teens. Risperdal and Abilify are also specifically approved for the same use in this age group. In association with the approval of Zyprexa and Seroquel, the FDA also stated [...]
In my next few blogs, I will provide answers to the most frequently asked questions fielded from conferences, seminars, e-mail and telephone contact. So if you’ve wondered about the answers to these questions or have encountered them in your work with clients, please read on! I’m delighted to be of service in this capacity. Q. [...]